Home
Live Updates
Instil Bio Announces Effective Date of 1-for-20 Reverse Stock Split : comparemela.com
Instil Bio Announces Effective Date of 1-for-20 Reverse Stock Split
DALLAS, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil” or the “Company”) (NASDAQ: TIL), a clinical-stage biopharmaceutical company focused on developing tumor infiltrating lymphocyte, or TIL, therapies for
Related Keywords
Dallas ,
Texas ,
United States ,
,
Nasdaq ,
Instil Bio Inc ,
Company Quarterly Report On Form ,
Nasdaq Capital Market ,
Nasdaq Capital ,
Co Stimulatory Antigen Receptor ,
Private Securities Litigation Reform Act ,
Quarterly Report ,
Region ,
comparemela.com © 2020. All Rights Reserved.